The original complaint was brought forward by the Alliance for Hippocratic Medicine in 2022 challenging the FDA's approval of mifepristone, the approval of its generic version and FDA rulings that ...
The FDA announced on Jan. 15 that it was revoking ... Under SB 41, violations of the ban could result in fines of up to ...
Nonetheless, Al Medwar, vice president of marketing and corporate development at BioDelivery says, “I completely support the FDA's ability to enforce this as necessary, including imposing fines ...
The FDA's contracts with the states to make the checks ended abruptly ... Selling to minors on a follow-up visit resulted in fines starting at $250 for a second offense, on up to $10,000 for a fifth ...
In December 2014, OtisMed Corporation agreed to pay more than $80 million after acknowledging that the company and its ex-CEO knowingly sold surgical cutting guides for knee replacements even though ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results